Chargement en cours...
Intralesional collagenase Clostridium histolyticum in the management of Peyronie’s disease: current best practice
The use of Clostridium histolyticum collagenase (CCH) has become increasingly widespread for the treatment of Peyronie’s disease (PD) in recent years. Numerous trials have confirmed both its safety and efficacy in appropriately selected patients with this condition. The purpose of this review is to...
Enregistré dans:
| Publié dans: | Ther Adv Urol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5851106/ https://ncbi.nlm.nih.gov/pubmed/29560030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287218755020 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|